2019 annual financial data
Sutro Biopharma 2019 Operating cash flow margin
Direct answer
Operating cash flow margin was -152.15%.
Operating income was -55,468,000 USD and net income was -55,744,000 USD.
Operating cash flow was -65,023,000 USD.
Get free Sutro Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 42,736,000 USD
- Operating income
- -55,468,000 USD
- Net income
- -55,744,000 USD
- Operating cash flow
- -65,023,000 USD